Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

194.42 -4.01 (-2.02%)
Streaming Delayed Price Updated: 10:44 AM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income ↗
ResMed Inc. offers a sustainable dividend with a 10-year growth history, backed by strong profitability, a low payout ratio, and a rock-solid balance sheet for durable passive income. 
Via Chartmill
News headline image
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence
ResMed Inc (NYSE:RMD): A Quality Dividend Stock Built on Strong Fundamentals ↗
Via Chartmill
ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength ↗
Via Chartmill
ResMed Inc. (NYSE:RMD) Emerges as a Prime Quality Investing Candidate ↗
Via Chartmill
ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗
Via Chartmill
ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock ↗
Via Chartmill
News headline image
ResMed (RMD) Stock Trades Down, Here Is Why
What Happened? Shares of medical device company ResMed (NYSE:RMD) fell 2.6% in the afternoon session after its Chairman and CEO, Michael J. Farrell, sold sha... 
Via StockStory
Topics Economy
News headline image
3 Reasons Not to Sleep on ResMed Stock ↗
ResMed is a leader in CPAP machines and other medical devices that help millions breathe better. 
Via The Motley Fool
News headline image
3 Healthcare Stocks to Target This Week
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se... 
Via StockStory
News headline image
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
From Resmed, Inc.
Via GlobeNewswire
ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience 
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks
News headline image
3 Quality Compounders to Consider Right Now
Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous... 
Via StockStory
News headline image
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its... 
Via StockStory
Topics Earnings Economy
News headline image
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth
Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share... 
Via StockStory
Topics Economy
News headline image
ResMed (RMD) Q2 2026 Earnings Call Transcript ↗
ResMed (RMD) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share was 3.2% above... 
Via StockStory
News headline image
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what you need to know. 
Via StockStory
News headline image
1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse
In a landmark shift for preventative medicine, researchers at Stanford University have unveiled SleepFM, a pioneering multimodal AI foundation model capable of predicting over 130 different health... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?
Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11.3% gain during that period. 
Via StockStory
Topics Stocks
News headline image
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
From Resmed, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.